Jump to the top of the page

Showing 940 – 950 of 1307 results

  • Applied Therapeutics Inc Initiation

    William Blair initiated research coverage of Applied Therapeutics, Inc. (APLT $5.04), a development-stage biotechnology company with a pipeline that includes late-stage assets in several rare diseases and some opportunities in larger indications.

  • Rekor Systems Inc Initiation

    William Blair initiated research coverage of Rekor Systems, Inc. (REKR $2.38), a company providing AI-based analytics software across public safety and licensing, transportation management, and urban mobility.

  • Neurogene Inc. Initiation

    William Blair initiated research coverage of Neurogene Inc. (NGNE $45.06), a genetic medicine company focused on the development of AAV-based therapies for the treatment of rare neurological diseases.

  • Bentley Systems Incorporated Initiation

    William Blair initiated research coverage of Bentley Systems, Incorporated (BSY $51.19), a leading provider of design, build, operate, and maintain software for the infrastructure industry.

  • Nasdaq Inc Initiation

    William Blair initiated research coverage of Nasdaq, Inc. (NDAQ $80.88), a leading global technology company with a broad range of offerings, including equities and options exchanges, data, investment analytics, software, marketplace technology, and corporate solutions.

  • General Dynamics Corporation Initiation

    William Blair initiated research coverage of General Dynamics Corporation (GD $225.50).

  • Sterling Infrastructure Inc Initiation

    William Blair initiated research coverage of Sterling Infrastructure, Inc. (STRL $177.15), which provides site development and construction services for the data center, e-commerce, semiconductor, transportation, and residential end-markets.

  • William Blair Appoints New Biotech Analyst Initiates on Two Companies

    William Blair, a global investment banking and asset management firm, is pleased to announce that it is expanding its coverage through a new appointment in the biotechnology equity research team.

  • The Honest Company Inc Initiation

    William Blair initiated research coverage of The Honest Company, Inc. (HNST $14.70), a next-generation, purpose-driven company focused on disrupting large consumer packaged goods categories by innovating clean and natural offerings that are safe, sustainable, and efficacious.

  • Kura Sushi USA, Inc. Initiation

    William Blair initiated research coverage of Kura Sushi USA, Inc. (KRUS $48.62). Kura Sushi is a revolving sushi bar with over 130 small plates alongside a full menu available via tableside ordering panels.

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures